Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Methods for identifying a subject at increased risk for developing AMD by determining the presence of protective genotypes at either the BF/C2 locus and at the CFH locus. More
Opticin has been found to exhibit anti-angiogenic (blood vessel formation) effects on a range of cell lines from different cancers More
Related Reports
Market Research Reports provided by reports.iptechex.com
Oct 2011 - 64 pages - $500
Jun 2010 - 411 pages - $2,695
Jun 2006 - 422 pages - $2,495
Apr 2011 - 951 pages - $4,995
Jan 2011 - 99 pages - $3,835
Aug 2010 - 80 pages - $1,215
Oct 2010 - 598 pages - $2,695
Wrigley's 5 Gum Case Study: remaining competitive in the gum market through a multi-sensory offering
Aug 2009 - 10 pages - $295
Sep 2010 - 21 pages - $99
Aug 2010 - 138 pages - $1,215
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Cataract
- Chlamydia trachomatis
- Conjunctivitis
- Corneal erosion
- Corneal ulcer
- Diabetic retinopathy
- Dry eyes
- Glaucoma
- Hyperopia
- Macular degeneration
- Ophthalmic disorder (other)
- Retinopathy
- Sight disorders
- Uveitis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us